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Background
A recent study showed that lumbar epidural steroid
injections increased osteoporotic spine fracture risk.
Aim
We further evaluated associations between steroid injec-
tions and osteoporotic fracture risk by analyzing the Medi-
care database and including large joint and transforaminal
steroid injections; as well as osteoporotic hip and wrist
fractures. A systemic effect would increase risk in all frac-
ture locations regardless of injection site. A local effect
would result in a disproportionate increased risk of spine
fractures when steroids were injected into the spine.
Design
Epidemiological study using national administrative data.
Methods
Patients who had a steroid injection into the epidural
space (ESI), transforaminal space (TSI) or large joint (LJSI)
were identified. Patients younger than 65 and those diag-
nosed with a prior osteoporotic fracture were excluded.
Patients were followed continuously until fracture, with-
drawal from Medicare or death. Kaplan-Meier survival
and Cox regression analysis were performed to determine
adjusted fracture risk (Adjusted Hazard Ratio (HR)) for
each type of injection, accounting for patient characteris-
tics such as age, sex, Charlson Comorbidity Index (CCMI),
Cushing’s syndrome or long term steroid use.
Results
Osteoporotic spine fracture risk after ESI, TSI or LJSI
was influenced by age, race, sex and CCMI. The risk
decreases with each additional ESI (HR=0.98), TSI
(HR=0.99) or LSJI (HR=0.96). Long term steroid use
increased spine fracture risk in ESI (HR=1.86) and LJSI
patients (HR=1.41). Osteoporotic hip fracture risk was
influenced by age, race, sex, CCMI, Cushing’s disease,
LJSI (HR=0.95) and TSI (HR=0.95), but not ESI. Osteo-
porotic wrist fracture risk was influenced by age, race,
sex, CCMI, LJSI (HR=0.91), but not by ESI or TSI.
Conclusions
Analysis of patients in the Medicare database showed
that ESI, TSI or LJSI decreased osteoporotic spine frac-
ture risk; but this may not be clinically relevant. Succes-
sive ESIs did not influence osteoporotic hip or wrist
fracture risk, while LJSIs reduced the risk. Prolonged
steroid exposure increases spine fracture risk in ESI and
LJSI patients. Acute exposure to exogenous steroids via
the epidural space, transforaminal space or large joints
does not seem to increase the risk of an osteoporotic
fracture of the spine, hip or wrist.
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